XML 20 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
shares in Millions, $ in Millions
Jun. 30, 2025
Dec. 31, 2024
Assets:    
Cash and cash equivalents $ 11,787 $ 8,586
Investments 2,386 2,407
Accounts receivable, net 40,651 36,469
Inventories 17,447 18,107
Other current assets 3,378 3,076
Total current assets 75,649 68,645
Long-term investments 29,858 28,934
Property and equipment, net 12,825 12,993
Operating lease right-of-use assets 15,512 15,944
Goodwill 91,203 91,272
Intangible assets, net 26,224 27,323
Separate accounts assets 1,858 3,311
Other assets 5,214 4,793
Total assets 258,343 253,215
Liabilities:    
Accounts payable 17,258 15,892
Pharmacy claims and discounts payable 26,338 24,166
Health care costs payable 15,271 15,064
Accrued expenses and other current liabilities 23,101 20,810
Other insurance liabilities 1,088 1,183
Current portion of operating lease liabilities 1,906 1,751
Short-term debt 3,040 2,119
Current portion of long-term debt 6,160 3,624
Total current liabilities 94,162 84,609
Long-term operating lease liabilities 14,328 14,899
Long-term debt 57,290 60,527
Deferred income taxes 3,603 3,806
Separate accounts liabilities 1,858 3,311
Other long-term insurance liabilities 4,769 4,902
Other long-term liabilities 4,782 5,431
Total liabilities 180,792 177,485
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,785 shares issued and 1,267 shares outstanding at June 30, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplus 50,020 49,661
Treasury stock, at cost: 518 shares at June 30, 2025 and December 31, 2024 (36,849) (36,818)
Retained earnings 63,936 62,837
Accumulated other comprehensive income (loss) 272 (120)
Total CVS Health shareholders’ equity 77,379 75,560
Noncontrolling interests 172 170
Total shareholders’ equity 77,551 75,730
Total liabilities and shareholders’ equity $ 258,343 $ 253,215
Shares repurchased (in shares) 518 518